SCHEMBL3587130

SCHEMBL3587130

CC(CCNCc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.45
LSS P48449 1/20 0.41
PPARA Q07869 5/20 0.40
HDAC1 Q13547 1/20 0.40
PPARD Q03181 3/20 0.40
KCNH2 Q12809 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
HTR5A P47898 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
ALDH1A1 P00352 1/20 0.38
EPHX2 P34913 1/20 0.38
PPARG P37231 1/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8921038 0.83 L3MBTL1 (0.43) HDAC1ALDH1A1MEN1KMT2A
SCHEMBL3545215 0.79 S1PR1 (0.48) S1PR1PPARAHDAC1PPARDKCNH2
SCHEMBL14415405 0.77 ALDH1A1 (0.53) S1PR1HDAC1KCNH2TMEM97ALDH1A1
SCHEMBL3545213 0.74 S1PR1 (0.48) S1PR1LSSPPARAHDAC1PPARD
SCHEMBL3587137 0.74 S1PR1 (0.46) S1PR1LSSPPARAHDAC1PPARD
SCHEMBL82782 0.74 NAMPT (0.46) ALDH1A1KMT2A
SCHEMBL3587119 0.71 HRH4 (0.46) S1PR1PPARAPPARDKCNH2TMEM97
SCHEMBL28579763 0.71 GRM8 (0.49) S1PR1PPARAPPARDEPHX2PPARG
SCHEMBL28579766 0.71 GRM8 (0.49) S1PR1PPARAPPARDEPHX2PPARG
SCHEMBL3587134 0.71 S1PR1 (0.47) S1PR1LSSPPARAHDAC1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144765-A1 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS HICKEY DEIDRE MARY BERNADETTE 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144765-A1 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS PLA2G4A, PLA2G4B, PLA2G1B S1PR1 191/4885LSS 667/4885PPARA 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.